What is the treatment approach for patients with functional hypothalamic amenorrhea (FHA) and anorexia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment approach for patients with functional hypothalamic amenorrhea (FHA) and anorexia should prioritize a multidisciplinary approach focusing on weight restoration, nutritional rehabilitation, and psychological support, with the primary goal of achieving and maintaining a healthy body weight, which often leads to spontaneous resumption of menses. This approach is supported by recent studies, including a narrative review published in 2025 1, which highlights the importance of addressing nutritional and energy deficiencies to protect bone health in women with FHA.

Key Components of Treatment

  • Weight restoration: aiming for a BMI of at least 18.5-19 kg/m²
  • Nutritional rehabilitation: starting with a caloric intake of approximately 30-40 kcal/kg/day, gradually increasing to 70-100 kcal/kg/day for weight gain of 0.5-1 kg per week
  • Psychological interventions: particularly cognitive behavioral therapy (CBT)
  • Hormonal therapy: considering transdermal oestradiol therapy with cyclic oral progestin for adolescents and women who have not had a return of menses after an adequate trial of nutritional, psychological, and/or modified exercise intervention, as recommended by Gordon et al. (2017) 1
  • Bone health protection: using hormone replacement therapy over combined oral contraception to prevent the risk of reduced bone mineral density and osteoporosis, as suggested by Gordon et al. (2017) 1

Additional Considerations

  • Regular monitoring of weight, menstrual function, bone density, and psychological status is necessary throughout treatment
  • Adequate calcium (1200-1500 mg/day) and vitamin D (800-1000 IU/day) supplementation is recommended for all patients
  • Recovery from FHA with anorexia can take months to years, and relapse prevention strategies are crucial for long-term success
  • The use of combined oral contraceptives should be limited to its contraceptive action or for other non-contraceptive benefits in specific medical situations, as it may inhibit IGF-1 production and decrease osteoblastic activity, as noted by Behary and Comninos (2022) 1

From the Research

Treatment Approach for Functional Hypothalamic Amenorrhea (FHA) and Anorexia

The treatment approach for patients with FHA and anorexia involves a multidisciplinary approach, addressing both organic and psychological aspects. Key considerations include:

  • A comprehensive assessment of nutrition status, anthropometry, eating disorders, fat tissue, and leptin levels 2
  • Dietary intervention focusing on increasing the caloric content of the diet to restore energy balance and menstrual function 3
  • Ensuring adequate kilocalories are provided throughout the day to avoid a negative energy balance 3
  • Increasing body fat percentage above 22% to restore menstrual function 3
  • Reducing the intensity of physical activity or training volume, while not giving up physical activity altogether 3
  • Ensuring adequate intake of micronutrients, reducing stress, and incorporating cognitive-behavioral therapy 3

Psychological Aspects

Psychological aspects of FHA and anorexia are crucial in the treatment approach. Studies have shown that:

  • Individuals with FHA demonstrate low self-esteem, depressive mood, anxiety, and inability to cope with daily stress 4
  • Adolescents with FHA and anorexia nervosa share common psychopathological aspects, such as maturity issues, social insecurity, and introversion 4
  • Nutritional counseling plays a significant role in the treatment of anorexia nervosa and bulimia nervosa, and can be applied to FHA as well 5

Management and Prevention

Management and prevention of FHA are essential to prevent adverse outcomes in bone density, cardiovascular risk profile, psychological well-being, and fertility. Studies suggest that:

  • Modification of nutritional intake and exercise are crucial in the management of FHA 6
  • Advancements in the understanding of the pathophysiological basis of FHA will aid in the development of novel therapeutic approaches 6
  • A comprehensive approach to the management of patients with FHA, including consultation with a gynecologist, psychotherapist, and nutritionist, is necessary 2

Related Questions

What treatment approach is recommended for a 33-year-old woman with functional hypothalamic amenorrhea (FHA) and irregular menstrual cycles, who has had some ovulatory cycles with letrozole?
What is the recommended treatment plan for a 23-year-old female with hypothalamic amenorrhea (HA) due to rapid weight loss, chronic stress, and anxiety, with lab results showing elevated Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels, low Estradiol levels, and thrombocytopenia (low platelet count)?
What is the diagnosis for a 16-year-old girl with secondary amenorrhea (absence of menstruation), normal Thyroid-Stimulating Hormone (TSH), Follicle-Stimulating Hormone (FSH), and Luteinizing Hormone (LH) levels, and recent significant weight loss with reduced appetite?
Does the patient's history of irregular menstrual cycles, amenorrhea, and response to letrozole (letrozole) and metformin (metformin) support a diagnosis of Functional Hypothalamic Amenorrhea (FHA)?
Do the blood results align with the hypothesis of functional hypothalamic amenorrhea (FHA)?
What to do for a patient with suspected Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) who received intravenous (IV) methylprednisolone (prednisolone) and a 2-day course of Intravenous Immunoglobulin (IVIG) one week ago, is currently on a tapering dose of oral prednisolone, and presents with a suspected relapse at a facility without plasma exchange services?
What is the recommended treatment for Streptococcus anginosus infections?
What are the treatment guidelines for acute appendicitis?
What is the acceptable duration between the first and second pulsed steroid (corticosteroid) courses?
Can anorexia nervosa (AN) cause hyperprolactinemia?
What are the guidelines for managing floaters (vitreous floaters)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.